Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 oct. 2020 07h00 HE | Source: Mateon Therapeutics, Inc.

MATEON TO PARTICIPATE IN MERIDIAN CLINICAL TRIALS SUMMIT

AGOURA HILLS, California, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, today announced...
09 mai 2019 07h00 HE | Source: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates

Continued progress made in four ongoing clinical studies as lenabasum advances towards 2020 data readouts in lead indications systemic sclerosis and cystic fibrosis Second clinical candidate...
12 mars 2019 07h00 HE | Source: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical Updates

●Pipeline of rationally-designed synthetic cannabinoids position Corbus to become the leader in treating inflammatory and fibrotic diseases by targeting the endocannabinoid system (ECS)...